SPONSORED CONTENT
Share:
Dr. Avi Blake describes the significance of lameness and the role of degenerative joint disease (DJD), how equine DJD occurs, and the clinical signs, diagnostics, and treatment options.
About the Expert:
Avi Blake, DVM
Avi Blake, DVM, a technical services veterinarian for American Regent Inc., is an equine and companion animal practitioner who’s spent 11 years in clinical practice—nine of those as an equine ambulatory practice owner. She’s also spent a decade as a veterinary technical and marketing writer and three years in companion animal pharmacovigilance.
Adequan® i.m. (polysulfated glycosaminoglycan) Safety Information
Adequan® i.m. polysulfated glycosaminoglycan (PSGAG) solution 100 mg/mL
INDICATIONS
Adequan® i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan (PSGAG). Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For additional safety information, please see full prescribing information at adequan.com.
Written by:
The Horse Staff
Related Articles
Stay on top of the most recent Horse Health news with
